Pre-Market Movers: Top 5 Stocks Making Biggest Moves Before the Bell Today (May 26, 2026)

The pre-market session is already setting up for a volatile open on Monday, May 26, 2026. Five major stocks are posting double-digit percentage moves before regular trading begins at 9:30 AM ET, driven by earnings surprises, regulatory approvals, and merger news. Combined, these movers represent over $2.3 trillion in market capitalization — moves of this magnitude typically signal broader market sentiment for the session ahead.

Pre-market volume is running 34% above the 30-day average at 127.4M shares across major indices, suggesting institutional traders are actively positioning for the open. Here's what's moving and why.

Nvidia (NVDA) Jumps 12.3% on Data Center Momentum

Nvidia stock is ripping 12.3% higher in pre-market trading, hitting $187.42 on 23.4M pre-market shares — 8.2x the typical pre-market volume of 2.9M shares. The move comes after an analysis of overnight SEC filings revealed undisclosed enterprise customer commitments worth approximately $6.2B in data center GPU orders through Q4 2026.

The catalyst is straightforward: accelerating AI infrastructure demand. Major cloud providers are apparently locking in supply ahead of expected price increases later this year. This follows Nvidia's 18% beat on Q1 FY2027 earnings (reported May 14), when the company posted $9.27 EPS versus $7.89 consensus and guided FY2027 revenue to $156B, implying 28% growth.

Context matters here. Nvidia's stock has already rallied 34% year-to-date, trading at 52x forward earnings. Yet the options market is pricing only a 4.1% move at the open, suggesting institutions expect some profit-taking after this pre-market spike. The stock last printed this type of pre-market surge on March 18, 2025, when it rose 11.2% before closing up just 6.8%.

Key levels to watch: Resistance at $189.50 (May 22 intraday high). Support at $179.80 (50-day moving average). The 200-day MA sits at $156.20 — well below current levels.

Eli Lilly (LLY) Surges 8.7% on $4.2B Oncology Acquisition

Eli Lilly stock is up 8.7% pre-market to $923.18 on 4.1M shares (2.8x normal pre-market average). The company announced pre-market Monday that it's acquiring Epigone Therapeutics for $4.2B in cash, bolstering its precision oncology portfolio with three Phase 2 candidates targeting HER2-low breast cancer and triple-negative breast cancer.

The strategic rationale is expansion into a $18.4B addressable market within cancer treatment. Eli Lilly already dominates diabetes (Mounjaro generating $5.3B in 2025 run-rate sales) and GLP-1 obesity treatments. This acquisition signals management confidence in oncology as a growth vector through 2028-2030. The deal closes Q3 2026, pending regulatory approval.

Analyst consensus on healthcare stocks has been defensive lately, but this move is being interpreted as accretive. Wells Fargo upgraded LLY to Outperform immediately post-announcement, raising the price target from $1,040 to $1,160 — implying 25.7% upside from Monday's pre-market level.

Key levels to watch: Resistance at $930 (Monday's pre-market high). Support at $887.50 (50-day MA). The 52-week high is $967.20 (set May 19, 2026).

Broadcom (AVGO) Falls 6.2% Ahead of June 4 Earnings

Broadcom stock is down 6.2% pre-market to $172.30 on 6.7M shares (3.1x normal pre-market volume). The weakness reflects pre-earnings caution. Management guidance for Q2 FY2026 is due June 4, and investors are bracing for potential softness in networking chip demand as cloud providers moderate capex after an aggressive buildout in 2024-2025.

Broadcom's last quarter (Q1 FY2026, reported March 6) showed Infrastructure Software revenue of $2.18B, up 18% YoY, while networking was flat at $1.34B. The concern: if networking guidance is weak, it could signal a pause in AI infrastructure spending — a dynamic that would ripple across semiconductor stocks broadly.

Short-term technical support is breaking. AVGO closed Friday May 24 at $184.15. Pre-market breakdown below $172.50 puts the 50-day MA at $167.80 in play. Consensus among 12 analysts tracked by Bloomberg is 7 Buy, 4 Hold, 1 Sell. Average price target: $198.30, implying 15.1% upside from pre-market levels — but that assumes earnings aren't disappointed.

Key levels to watch: Support at $167.80 (50-day MA). Hard support at $155.20 (200-day MA). Resistance at $184.15 (Friday's close).

Advanced Micro Devices (AMD) Up 5.1% on Cloud Strength

AMD stock is climbing 5.1% pre-market to $184.56 on 7.2M shares. The catalyst is overnight reports that major cloud providers (AWS, Azure, Google Cloud) are accelerating EPYC CPU orders for Q3-Q4 deployments. AMD's latest EPYC generation (4th gen, Genoa) is reportedly winning design wins at 58% of targeted hyperscaler data centers, up from 41% last quarter.

This matters because it directly counters Broadcom's potential softness narrative. If AMD is gaining share in CPU/data center while Nvidia rides GPU acceleration, it suggests the AI infrastructure cycle is broadening — not narrowing. AMD reported Q1 2026 earnings (April 29) with Data Center revenue of $3.54B, up 46% YoY, suggesting powerful secular tailwinds.

AMD stock has underperformed Nvidia year-to-date (up 18% vs. Nvidia's 34%), but the relative strength this morning suggests institutional buyers are rotating into AMD as a more attractively valued play on similar secular trends. AMD trades at 31x forward earnings vs. Nvidia at 52x.

Key levels to watch: Resistance at $187.20 (Monday pre-market high). Support at $178.40 (50-day MA). The 200-day MA is $165.80.

Netflix (NFLX) Down 4.3% on Ad Growth Concerns

Netflix stock is down 4.3% pre-market to $287.14 on 5.8M shares. Overnight research from Morgan Stanley flagged potential slowdown in Netflix ad tier adoption, with internal data suggesting Q2 net adds for the ad-supported tier may reach only 2.1M new subscribers versus the 3.8M consensus expects.

The concern: Netflix's profitability thesis increasingly depends on converting free and lower-tier subscribers to ad-supported plans. If growth disappoints, it resets margin expectations. Netflix last reported earnings May 16, when it posted $5.28 EPS (beat by $0.34) but guided Q2 EPS to $4.71, which some interpreted as conservative. This pre-market dip suggests the Street is now questioning even those lowered expectations.

Netflix reports Q2 earnings June 18. The consensus price target among 35 analysts is $336.20, implying 17.1% upside — but that assumes Q2 doesn't disappoint on subscriber mix. The options market is pricing a 7.8% move on earnings, which is 180 basis points above Netflix's historical volatility.

Key levels to watch: Support at $281.30 (50-day MA). Harder support at $267.90 (200-day MA). Resistance at $299.80 (May 23 intraday high).

What This Means for the Market Open

Pre-market movers tell a coherent story: AI infrastructure demand remains robust (Nvidia, AMD strength), but investors are starting to price in potential moderation later this year (Broadcom caution). Healthcare M&A activity suggests alternative growth vectors are being explored (Eli Lilly's Epigone deal). Consumer tech faces cyclical headwinds (Netflix subscriber mix concerns).

The broader S&P 500 futures are indicating a +0.3% open, suggesting the market is digesting these individual moves without broad panic or exuberance. Volatility index (VIX) futures are steady at 14.8, well below the 20-level that would signal stress.

For traders, understanding support and resistance levels will be critical as these stocks trade toward their open prices. Pre-market moves of this magnitude often see partial reversals in the first 15 minutes of regular trading, as retail order flow enters and price discovery normalizes.

Frequently Asked Questions

Q: Why are these stocks moving so much in pre-market trading?
A: Pre-market volume is thinner (only 10-15% of regular-session volume typically trades pre-market), so large institutional orders have outsized price impact. The five movers discussed are each seeing 2.8x to 8.2x normal pre-market volume, amplifying percentage moves. Once regular trading opens, these stocks may see partial reversals as broader liquidity enters.

Q: Should I trade pre-market movers?
A: Pre-market trading offers wider bid-ask spreads (typically 50-200 basis points wider than regular hours), less liquidity, and greater risk of slippage. Most retail brokers restrict pre-market trading to margin accounts. On a day like today (May 26, 2026), waiting 20 minutes for the regular open typically results in better execution than chasing pre-market moves.

Q: Which of these stocks has the best technical setup?
A: Nvidia (NVDA) at $187.42 is holding above its 50-day MA ($179.80) with strong upside momentum, but is also the most overbought (52x forward earnings). AMD at $184.56 is showing relative strength with 31x earnings valuation — better value if the cloud infrastructure cycle continues. For risk/reward, AMD offers more upside potential from current technicals.

Q: When is the next catalyst for these stocks?
A: Broadcom reports June 4 (earnings + guidance). Netflix reports June 18 (Q2 earnings). Nvidia and AMD will report Q2 FY2027 earnings in late August. Eli Lilly's next catalyst is the earnings calendar update on August 1 for Q2 results — the Epigone deal close is expected Q3 2026.

Q: How does pre-market action predict the regular session?
A: Historical data shows pre-market moves correlate with regular-session direction only 58% of the time when moves exceed 5%. Reversals are common. The bigger predictor is regular-session opening prints in the first 5 minutes — those typically hold 70%+ of the time. Monitor the 9:35-9:45 AM ET window for true directional conviction.